Jane Street’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$12M Buy
+185,200
New +$8.39M ﹤0.01% 2609
2023
Q1
– Sell
-48,500
Closed -$553K – 9097
2022
Q4
$553K Buy
+48,500
New +$719K ﹤0.01% 5948
2022
Q2
– Sell
-7,600
Closed -$281K – 9732
2022
Q1
$281K Buy
7,600
+700
+10% +$27.3K ﹤0.01% 8502
2021
Q4
$314K Sell
6,900
-12,900
-65% -$673K ﹤0.01% 8082
2021
Q3
$1.26M Buy
19,800
+13,300
+205% +$1.01M ﹤0.01% 5449
2021
Q2
$595K Sell
6,500
-3,200
-33% -$254K ﹤0.01% 6915
2021
Q1
$660K Buy
9,700
+2,600
+37% +$202K ﹤0.01% 6275
2020
Q4
$514K Buy
+7,100
New +$411K ﹤0.01% 5701
2020
Q3
– Sell
-8,100
Closed -$287K – 7179
2020
Q2
$287K Buy
+8,100
New +$231K ﹤0.01% 5905

Other funds holding CDNA

Jane Street's CDNA Position: Q3 2026 in Review

Jane Street sold out of CareDx (CDNA) in Q3 2026, closing a stake of 470,273 shares — an estimated $21.3M sold.

Jane Street first reported a position in CDNA in Q3 2019 and held it in 23 quarters. The position peaked at $13.4M in Q2 2026. 308 funds tracked by Wall St. Rank hold CDNA as of Q3 2026.

  • Jane Street reported no remaining CareDx position as of Q3 2026 after selling out during the quarter.
  • Jane Street sold 470,273 CareDx shares in Q3 2026, an estimated $21.3M.
  • Jane Street first reported a position in CareDx in Q3 2019 and held it in 23 quarters.
  • Jane Street's CareDx position peaked at $13.4M in Q2 2026.
  • 308 funds tracked by Wall St. Rank held CareDx as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.